AaviGen
PrivateLast Round
Accelerator
Jun 4, 2025
Total Funding Raised
$18.85M
Company Overview
AaviGen is a biotechnology company that develops precision gene therapies for cardiovascular and cardiopulmonary diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AaviGen Comparables
Compare AaviGen with similar companies based on industry and business-model similarity.
AaviGen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 4, 2025 | ||||
| Series B | Jul 26, 2023 |
AaviGen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| dievini Hopp BioTech holding | Series B |
| German Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 4, 2025
Received funding from German Accelerator.
- Jul 26, 2023
$19M round led by DH-LT Investments GmbH.
AaviGen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AaviGen's valuation, stock price, and market status.